We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ACAB market cap is 47.13M. The company's latest EPS is USD 0.3455 and P/E is 16.70.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -315k | -393k | -1.14M | -394k | -391k |
| Net Income | -44k | -7k | -1.05M | -339k | -335k |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -2k | -2.05M | -1.67M |
| Net Income | -2k | 887k | 2.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 37.52M | 37.37M | 7.53M | 7.9M | 7.86M |
| Total Liabilities | 16.01M | 45.89M | 17.11M | 17.81M | 19.54M |
| Total Equity | -15.06M | -15.82M | -16.99M | -17.4M | -17.81M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 361k | 310.56M | 37.37M |
| Total Liabilities | 338k | 12.64M | 45.89M |
| Total Equity | 23k | -11.18M | -15.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -1.51M | -3.85M | -265k | -528k | -776k |
| Investing | 278.6M | 278.44M | 29.69M | 29.66M | 29.64M |
| Financing | -276.54M | -274.73M | -29.68M | -29.16M | -29.11M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -1.19M | -3.85M |
| Investing | N/A | -305.67M | 278.44M |
| Financing | N/A | 307.25M | -274.73M |
| Market Cap | 47.13M |
| Price to Earnings Ratio | 16.70 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 178.09 |
| Price to Book Ratio | -5.53 |
| Dividend Yield | - |
| Shares Outstanding | 8.17M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -45.41% |
| 52 Week High | 13.20 |
| 52 Week Low | 5.75 |
| Spread (Intraday) | 0.08 (1.25%) |
| Company Name | Atlantic Coastal Acquisition Corporation II |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.abpro.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
